Oscar Health (NYSE:OSCR) Hits New 1-Year High – What’s Next?

Oscar Health, Inc. (NYSE:OSCR) hit a new 52-week high during trading on Monday . The stock traded as high as $26.06 and last traded at $26.5660, with a volume of 1727899 shares. The stock had previously closed at $24.51.

Analysts Set New Price Targets

OSCR has been the subject of several research reports. UBS Group boosted their price objective on Oscar Health from $15.00 to $20.00 and gave the stock a “neutral” rating in a research note on Thursday, May 7th. Robert W. Baird raised their target price on Oscar Health from $15.00 to $19.00 and gave the company a “neutral” rating in a research report on Thursday, May 7th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Oscar Health in a research note on Tuesday, April 21st. Barclays increased their price objective on Oscar Health from $21.00 to $30.00 and gave the company an “equal weight” rating in a research note on Tuesday, May 26th. Finally, Zacks Research upgraded Oscar Health from a “hold” rating to a “strong-buy” rating in a report on Thursday, May 7th. One investment analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $20.22.

Oscar Health Stock Up 7.1%

The company has a debt-to-equity ratio of 0.26, a current ratio of 1.11 and a quick ratio of 1.11. The company has a market capitalization of $7.92 billion, a PE ratio of -44.70, a P/E/G ratio of 1.71 and a beta of 2.37. The business’s 50 day simple moving average is $18.39 and its 200 day simple moving average is $16.07.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $2.07 earnings per share for the quarter, beating the consensus estimate of $1.11 by $0.96. The business had revenue of $4.65 billion during the quarter, compared to analysts’ expectations of $4.90 billion. Oscar Health had a negative net margin of 0.30% and a negative return on equity of 3.26%. The business’s revenue for the quarter was up 52.6% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.92 EPS. As a group, analysts anticipate that Oscar Health, Inc. will post 0.47 earnings per share for the current fiscal year.

Insider Transactions at Oscar Health

In other Oscar Health news, CEO Mark T. Bertolini acquired 1,000,000 shares of the stock in a transaction that occurred on Monday, April 6th. The stock was bought at an average cost of $11.92 per share, for a total transaction of $11,920,000.00. Following the completion of the transaction, the chief executive officer owned 10,196,876 shares of the company’s stock, valued at approximately $121,546,761.92. The trade was a 10.87% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, insider Janet Liang sold 12,475 shares of the firm’s stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $21.94, for a total value of $273,701.50. Following the sale, the insider directly owned 259,057 shares of the company’s stock, valued at approximately $5,683,710.58. This trade represents a 4.59% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 189,660 shares of company stock valued at $4,283,140 in the last ninety days. 25.11% of the stock is currently owned by corporate insiders.

Institutional Trading of Oscar Health

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Jones Financial Companies Lllp increased its position in shares of Oscar Health by 7,473.3% during the first quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock valued at $30,000 after acquiring an additional 2,242 shares during the last quarter. Strs Ohio purchased a new stake in shares of Oscar Health in the 1st quarter valued at approximately $30,000. Fifth Third Bancorp lifted its holdings in shares of Oscar Health by 148.7% in the 4th quarter. Fifth Third Bancorp now owns 2,363 shares of the company’s stock worth $34,000 after acquiring an additional 1,413 shares during the last quarter. Quarry LP lifted its holdings in shares of Oscar Health by 439.8% in the 3rd quarter. Quarry LP now owns 1,803 shares of the company’s stock worth $34,000 after acquiring an additional 1,469 shares during the last quarter. Finally, Harel Insurance Investments & Financial Services Ltd. purchased a new position in shares of Oscar Health during the 1st quarter worth approximately $49,000. 75.70% of the stock is currently owned by hedge funds and other institutional investors.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.